2019
DOI: 10.1007/s00392-019-01570-3
|View full text |Cite
|
Sign up to set email alerts
|

Transcatheter aortic valve replacement acutely improves left ventricular mechanical efficiency in severe aortic stenosis: effects of different phenotypes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
4
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 30 publications
3
4
0
Order By: Relevance
“…which was contributed to the decrease of PVA after TAVI. The improvement of energy transfer and LV efficiency were consistent with previous studies (Bastos et al, 2019;Marino et al, 2020). Conventional method of PV analysis has major limitations such as the complexity for pressure/flow acquisition and its invasiveness.…”
Section: Tavisupporting
confidence: 90%
“…which was contributed to the decrease of PVA after TAVI. The improvement of energy transfer and LV efficiency were consistent with previous studies (Bastos et al, 2019;Marino et al, 2020). Conventional method of PV analysis has major limitations such as the complexity for pressure/flow acquisition and its invasiveness.…”
Section: Tavisupporting
confidence: 90%
“…Literature reports on changing cardiac mechanoenergetics during transcatheter valvular interventions are sparse. Marino et al 10 reported a decrease in PVA from 16.424 (standard deviation [SD] AE 6.268) mmHg mL À1 to 12.053 (SD AE 5.260) following TAVR (p < 0.001) using noninvasive PVL-monitoring. Based on these numbers, and assuming normal distribution and moderate to strong negative intrapatient correlation, 65 patients will be needed to detect a significant change in PVA with 0.05 alpha and 90% power for patients undergoing TAVR.…”
Section: Sample Size Calculationmentioning
confidence: 99%
“…In patients with mild systolic HF and metabolic syndrome, MEEi increased after 12 months in patients randomized to an aldosterone receptor antagonist on the top of optimal therapy, which was associated with improved LV diastolic function and decreased levels of B-type natriuretic peptide compared to placebo [60]. Recently, in a small group of aortic stenosis subjects, a surrogate estimate of MVO 2 dropped and the EW-to-TME ratio increased immediately after transcatheter aortic valve implantation (TAVI), and over-median post-TAVI rises in the ratio (normalized to the individualized estimate of MVO 2 ) were associated with a lower risk of all-cause death over an approximately 3-year follow up [61].…”
Section: Implications For Future Research-treatment Effects On Meementioning
confidence: 99%